Galantamine does not cause aggravated orthostatic hypotension in people with alzheimer's disease

Journal of the American Geriatrics Society

Volumn 58, Issue 2, 2010, Pages 409-410

  Van Beek, Arenda H E A ^a   Sijbesma, Jaap C ^a   Olde Rikkert, Marcel G M ^a   Claassen, Jurgen A H R ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GALANTAMINE;

ALZHEIMER DISEASE; BLOOD PRESSURE MEASUREMENT; ELECTROCARDIOGRAPHY; HEART HEMODYNAMICS; HEART RATE; HEART RHYTHM; HUMAN; LETTER; ORTHOSTATIC HYPOTENSION;

AGED; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CHOLINESTERASE INHIBITORS; FEMALE; GALANTAMINE; HEMODYNAMICS; HUMANS; HYPOTENSION, ORTHOSTATIC; MALE; NETHERLANDS; SYNCOPE, VASOVAGAL;

EID: 75749155428     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2009.02712.x     Document Type: Letter

References (4)

1. Gill SS, Anderson GM, Fischer HD et al. Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: A population-based cohort study. Arch Intern Med 2009 169 : 867 873.
2. Claassen JA, van Beek AH, Olde Rikkert MG. Short review: Acetylcholinesterase-inhibitors in Alzheimer's disease have opposing effects on blood pressure and cerebral perfusion. J Nutr Health Aging 2009 13 : 231 233.
3. van Beek AH, Claassen JA, Rikkert MG et al. Cerebral autoregulation: An overview of current concepts and methodology with special focus on the elderly. J Cereb Blood Flow Metab 2008 28 : 1071 1085.
4. Qaseem A, Snow V, Cross JT Jr. et al. Current pharmacologic treatment of dementia: A clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med 2008 148 : 370 378.